Cadrenal Therapeutics Inc (CVKD)
0.4905
+0.03
(+5.48%)
USD |
NASDAQ |
May 03, 16:00
0.4926
0.00 (0.00%)
After-Hours: 20:00
Cadrenal Therapeutics Price to Book Value: 1.021 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.021 |
| May 02, 2024 | 0.9677 |
| May 01, 2024 | 0.9459 |
| April 30, 2024 | 0.9157 |
| April 29, 2024 | 0.9388 |
| April 26, 2024 | 0.8959 |
| April 25, 2024 | 0.8815 |
| April 24, 2024 | 0.8915 |
| April 23, 2024 | 0.8876 |
| April 22, 2024 | 0.8476 |
| April 19, 2024 | 0.8358 |
| April 18, 2024 | 0.8945 |
| April 17, 2024 | 0.8776 |
| April 16, 2024 | 0.8114 |
| April 15, 2024 | 0.8428 |
| April 12, 2024 | 0.8589 |
| April 11, 2024 | 0.9074 |
| April 10, 2024 | 0.9205 |
| April 09, 2024 | 0.8505 |
| April 08, 2024 | 1.061 |
| April 05, 2024 | 1.163 |
| April 04, 2024 | 1.266 |
| April 03, 2024 | 1.244 |
| April 02, 2024 | 1.288 |
| April 01, 2024 | 1.288 |
| Date | Value |
|---|---|
| March 28, 2024 | 1.270 |
| March 27, 2024 | 1.332 |
| March 26, 2024 | 1.350 |
| March 25, 2024 | 1.311 |
| March 22, 2024 | 1.353 |
| March 21, 2024 | 1.311 |
| March 20, 2024 | 1.249 |
| March 19, 2024 | 1.186 |
| March 18, 2024 | 1.165 |
| March 15, 2024 | 1.224 |
| March 14, 2024 | 1.238 |
| March 13, 2024 | 1.220 |
| March 12, 2024 | 1.207 |
| March 11, 2024 | 1.354 |
| March 08, 2024 | 1.394 |
| March 07, 2024 | 1.342 |
| March 06, 2024 | 1.074 |
| March 05, 2024 | 1.099 |
| March 04, 2024 | 1.126 |
| March 01, 2024 | 1.172 |
| February 29, 2024 | 1.192 |
| February 28, 2024 | 1.141 |
| February 27, 2024 | 1.019 |
| February 26, 2024 | 1.062 |
| February 23, 2024 | 1.067 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6105
Minimum
Nov 13 2023
8.305
Maximum
Jul 12 2023
2.443
Average
1.794
Median
Jan 22 2024
Price to Book Value Benchmarks
| Tenax Therapeutics Inc | 0.9285 |
| Syra Health Corp | 2.388 |
| Minerva Neurosciences Inc | -- |
| Adverum Biotechnologies Inc | 2.594 |
| Genprex Inc | 0.6285 |
Price to Book Value Related Metrics
| Price | 0.4905 |
| Earnings Yield | -140.7% |
| Market Cap | 7.852M |